title: Olanzapine and quetiapine use during breastfeeding: excretion into breast milk and safe breastfeeding strategy.
authors: Department of Medical Pharmacology Dokuz Eylul University School of Medicine Izmir Turkey burcaydin@gmail.com ENV Engineering and Environmental Consulting Ankara, Turkey ARGEFAR Drug Development and Pharmacokinetics Research Center Ege University Izmir, Turkey Department of Psychiatry Dokuz Eylul University School of Medicine Izmir, Turkey.
authors: Burc
authors: B
authors: Aydin
authors: Tugba
authors: T
authors: Nayir
authors: Selma
authors: S
authors: Sahin
authors: Aysegul
authors: A
authors: Yildiz
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019540:Area Under Curve; D001569:Benzodiazepines / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy / Q000378:metabolism; D001942:Breast Feeding; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008895:Milk, Human / Q000378:metabolism*; D000077152:Olanzapine; D000069348:Quetiapine Fumarate / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014427:Twins
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D000077152:Olanzapine